arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Johnson & Johnson

JNJ Health Care Biotechnology: Pharmaceutical Preparations
$275.71
▲ +0.2% Today
as of Sep 4, 16:50 ET
Last 30 days +3.49% Jul 27 → Sep 04
$252.49 $259.45 $266.42 $273.39 $280.35 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$275.13
High
$277.80
Low
$274.75
Volume
$4M
Avg Vol
$8M
Mkt Cap
$671.0B
P/E (TTM)
41.05
Beta
52w High
$281.07
52w Low
$173.33
Div Yield
Shares Out

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 1 ● 24 ▼ 0
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$173
$281
95% of range
Avg surprise (last 2)
+2.6%
Avg reaction (last 1)
+6.2%
100% positive
Latest IV / EM
25%
EM ±1.0% · $280 · Sep 4

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.03$2.53$5.09$7.65$10.21 Actual $-0.03Actual $1.96Actual $10.21Actual $1.34Actual $1.93Actual $1.11Actual $4.54Actual $2.77Est $2.66Actual $2.80Est $2.77Actual $2.14Actual $2.27 AprJulOctMarJunSepMarJun/2025Sep/2025MarJun
Revenue vs Net Income Revenue Net income
$0$6.6B$13.3B$19.9B$26.6B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Sun Jun 28, 2026Jun 2026 $2.27 financials
Sun Mar 29, 2026Mar 2026 $2.14 financials
Tue Oct 14, 2025Sep/2025 $2.80 $2.77 +1.1% earnings
Wed Jul 16, 2025Jun/2025 $2.77 $2.66 +4.1% +6.2% earnings
Sun Mar 30, 2025Mar 2025 $4.54 financials
Sun Sep 29, 2024Sep 2024 $1.11 financials
Sun Jun 30, 2024Jun 2024 $1.93 financials
Sun Mar 31, 2024Mar 2024 $1.34 financials
Sun Oct 1, 2023Oct 2023 $10.21 financials
Sun Jul 2, 2023Jul 2023 $1.96 financials
Sun Apr 2, 2023Apr 2023 $-0.03 financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$25.31B$24.06B$23.99B$23.74B$21.89B$22.47B
Cost of revenue$8.05B$8.11B$7.30B$7.63B$7.36B$6.96B
Gross profit$17.26B$15.96B$16.69B$16.11B$14.54B$15.51B
Operating income
Net income$5.53B$5.24B$5.15B$5.54B$11.00B$2.69B
EPS (diluted)$2.27$2.14$2.12$2.29$4.54$1.11

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$20.42B$21.69B$19.71B$18.23B$18.58B$38.47B$24.11B$19.98B
Inventory$15.14B$14.58B$14.19B$14.15B$13.41B$12.66B$12.44B$12.60B
Total current assets$59.77B$59.17B$55.62B$54.61B$54.50B$71.55B$55.89B$53.25B
Total assets$201.06B$200.89B$199.21B$192.82B$193.39B$193.67B$180.10B$178.29B
Long-term debt$37.34B$37.53B$39.44B$39.41B$39.23B$38.35B$30.65B$31.29B
Total liabilities$116.09B$119.71B$117.67B$113.54B$114.92B$115.56B$108.61B$108.13B
Total equity$84.97B$81.19B$81.54B$79.28B$78.47B$78.11B$71.49B$70.16B

Implied volatility — last 90 days

22%28%34%40%46% Jun 07 — IV 27% · EM ±2.5%Jun 08 — IV 26% · EM ±2.2%Jun 09 — IV 30% · EM ±2.2%Jun 10 — IV 29% · EM ±1.7%Jun 11 — IV 35% · EM ±1.5%Jun 15 — IV 27% · EM ±1.9%Jun 16 — IV 26% · EM ±1.5%Jun 17 — IV 35% · EM ±1.5%Jun 19 — IV 25% · EM ±2.7%Jun 22 — IV 27% · EM ±2.2%Jun 23 — IV 28% · EM ±2.1%Jun 24 — IV 28% · EM ±1.7%Jun 25 — IV 22% · EM ±0.9%Jun 29 — IV 31% · EM ±5.5%Jun 30 — IV 31% · EM ±5.3%Jul 01 — IV 31% · EM ±5.2%Jul 02 — IV 35% · EM ±5.6%Jul 03 — IV 36% · EM ±5.6%Jul 06 — IV 37% · EM ±5.2%Jul 07 — IV 42% · EM ±5.5%Jul 08 — IV 38% · EM ±4.8%Jul 09 — IV 38% · EM ±4.5%Jul 10 — IV 34% · EM ±3.8%Jul 13 — IV 44% · EM ±3.7%Jul 14 — IV 46% · EM ±3.3%Jul 15 — IV 36% · EM ±2.1%Jul 16 — IV 34% · EM ±1.4%Jul 20 — IV 28% · EM ±2.3%Jul 21 — IV 28% · EM ±2.0%Jul 22 — IV 28% · EM ±1.7%Jul 23 — IV 35% · EM ±1.5%Jul 27 — IV 28% · EM ±2.3%Jul 28 — IV 32% · EM ±2.3%Jul 29 — IV 29% · EM ±1.7%Jul 30 — IV 33% · EM ±1.4%Aug 03 — IV 28% · EM ±2.3%Aug 04 — IV 33% · EM ±2.4%Aug 05 — IV 29% · EM ±1.7%Aug 06 — IV 32% · EM ±1.4%Aug 10 — IV 28% · EM ±2.3%Aug 11 — IV 24% · EM ±1.7%Aug 12 — IV 26% · EM ±1.5%Aug 13 — IV 25% · EM ±1.0%Aug 17 — IV 24% · EM ±2.0%Aug 18 — IV 27% · EM ±1.9%Aug 19 — IV 26% · EM ±1.5%Aug 20 — IV 29% · EM ±1.2%Aug 24 — IV 24% · EM ±2.0%Aug 25 — IV 25% · EM ±1.8%Aug 26 — IV 26% · EM ±1.5%Aug 27 — IV 31% · EM ±1.3%Aug 31 — IV 24% · EM ±2.0%Sep 01 — IV 25% · EM ±1.8%Sep 02 — IV 28% · EM ±1.7%Sep 03 — IV 25% · EM ±1.0%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.